Innovative biotechnology company founded in 2023 and based in Irvine, California
Raised to date
$21M
of $34.4M offered across 5 Form D filings
The company is dedicated to developing cutting-edge medical technologies and solutions within the healthcare industry, aiming to address significant health-related challenges through novel biological and technological advancements.
Restora Medical stands out by focusing on the creation of innovative technologies tailored to improve health outcomes, although specific details about their unique offerings are not yet disclosed.
$15M equity round, first sold May 2026: $11.5M sold, $3.5M still open
$15M round, first sold May 2026: $11.5M sold, $3.5M still open
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Jun 18, 2026 | Equity | $3.5M/ $7.4M | Form D/A |
| Jun 18, 2026 | Equity | $6M/ $12M | Form D/A |
| Jun 18, 2026 | Equity | $11.5M/ $15M | Form D/A |
| May 29, 2026 | Equity | $11.5M/ $15M | Form D |
| Mar 6, 2025 | Equity | $6M/ $12M | Form D |
Medical Technology
While specific products have not been detailed in available sources, Restora Medical focuses on developing innovative medical technologies that aim to improve patient outcomes and address unmet health needs in the market.
Built for
Healthcare providers and medical facilities
